1/ How do we train scientists to do peer review or curate new discoveries?
@amycfanphd and I explored how a community-based trainee-focused preprint journal club can help foster these skills. Excited to share what we learned here:
nature.com/articles/d41586-0…
Our @Nature paper is out!
It's been known for a while that long-term dietary habits can affect how our immune system behaves. But what about much briefer changes in diet?
In mice, we found that even a few days of dietary change (think cheat days...or perhaps salad Sundays) at the onset of inflammation can profoundly alter disease severity and establish lasting inflammatory memory in tissues, even after the diet changes back.
nature.com/articles/s41586-0…
This work was led by two extraordinarily dedicated and inexhaustible members of our lab: former graduate student @OwenJ457 and former technician John Tayeri. It was also an exercise in collaborative science as many labs @UCSF and @Stanford came together to bring this over the finish line - special thanks to @gardnerlabUCSF, @Molofsky_lab, @alexis_combes, @Treg_Mike. Deeply grateful to everyone who contributed!
UCSF Wins Big, From Gamechangers to Startups to Life Achievement
Special shoutout to ImmunoX member, Dr. Susan Lynch, recipient of the Disruptive Research Award!
ucsf.edu/news/2026/09/432636…
UCSF-Led Group Awarded $9 Million for Heart Inflammation Research
Congratulations to ImmunoX member, Dr. Javid Moslehi, and team on this big win!
ucsf.edu/news/2026/08/432481…
Scientists at Gladstone and @UCSF developed a method to genetically edit myeloid cells, immune cells that act as the body’s first responders.
@NatureBiotech@jccarnevalebit.ly/3SGx5Fw
Four years ago, a mystery case led Core Investigator @jvpluv to discover a new diagnosis (ABCD). Today his team published one of the largest clinical surveys of unexplained spinal cord disease to date in @JAMANeuro, finding ABCD in roughly half of patients.
Incredibly excited to share the first major paper from my lab @carnevale_lab led by postdoc Qi Liu @GladstoneInst@UCSF executing the first ever genome-wide in vivo screens for genetic modifications to enhance human T cell therapies for solid tumors. Now in @Nature: nature.com/articles/s41586-0…
👏 🔬 CRI is proud to announce the 2026 CLIP and Tech Impact Award projects, supporting innovative research and cutting-edge technologies that have the potential to accelerate the next generation of cancer immunotherapies. Learn more: bit.ly/4hr5ty8#CancerResearcher
🚨 New @NIH support for @UCSF General Surgery Resident Dr. Eva Mae Gillis-Buck. Her project, "Defining the role of RORγt-lineage antigen-presenting cells in maternal-fetal tolerance," has received funding from the #NIAID to advance maternal-fetal immunology & healthy pregnancy👏
Promising new research from PICI member researcher @LuRongze at the @NeurosurgUCSF highlights a potential new therapeutic approach for aggressive, treatment-resistant pediatric brain tumors.
Published in the @jclinicalinvest, the research shows that targeting PP2A induced tumor cell senescence, strengthened anti-tumor immune responses, and significantly extended survival in preclinical medulloblastoma models. The findings identify PP2A as a promising therapeutic target for high-risk disease.
By helping make difficult-to-treat pediatric brain tumors recognizable to the immune system, this research lays important groundwork for future therapies aimed at improving outcomes for children facing these devastating cancers.
Learn more here: jci.org/articles/view/196753
Proposing a new approach for aggressive, treatment-resistant pediatric brain tumors.
Rongze Olivia Lu & team @NeurosurgUCSF target protein phosphatase 2A (PP2A) to induce tumor cell senescence and boost immune response in medulloblastoma models: doi.org/10.1172/JCI196753#medulloblastoma
I'm maintaining an active list of biology-related job openings at various levels (PIs, staff scientists, postdocs, PhDs, etc.). Please feel free to subscribe or contribute! github.com/brianpenghe/Bio-J…
Together with @BrianHie's lab, we are looking for a lab manager to join the team @arcinstitute. If you love to organize, optimize, and accelerate scientific discovery, please consider applying! job-boards.greenhouse.io/arc…
We are recruiting a lab manager @arcinstitute, alongside @jvpluv's lab, to support our work on ensuring that AI for biology benefits humanity.
This role will spearhead operations across diverse, very exciting projects in the works. Please consider joining us!
Honored to receive a CRI STAR Award! Immensely grateful to the @CancerResearch Institute for backing bold ideas and supporting our mission to decode the rules of T cell signaling and make in vivo T cell reprogramming a reality. Excited for what comes next! 🚀
🌟CRI is proud to announce the 2026 class of Lloyd J. Old STARs- 5 bold scientists pushing the boundaries of immunotherapy and reimagining what’s possible in the fight against cancer. Discover how their fearless ideas are reshaping the future of treatment: bit.ly/3SDls21